An interventional study of a pragmatic EEG-guided anesthetic protocol in Delirium, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 263 studies in Delirium with a site in United States — 37 open to participants now, 60 under way, 7 of them phase 3. Delirium · United States.
Among the 263 studies in Delirium with a site in United States, this one is the 12th largest by enrollment of the 194 interventional ones that give a count, is one of 17 that started in 2015, is one of 105 with no phase, and was the 86th registered.
935 studies on the registry are indexed under Delirium; 188 are open to participants now.
Browse Delirium studies →37 of the 263 studies in Delirium with a site in United States are open now. Recruiting first, the newest first:
The Methodist Hospital Research Institute · Sites in United States
Ages up to 65
Northwestern University · Sites in United States
Ages 18+
Ceribell Inc. · Sites in United States
Ages 18+
Washington University School of Medicine · Sites in United States
Ages 60+
Indiana University · Sites in United States
Ages 50+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.
This study: 60 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
263 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 32 · Phase 3 25 · Phase 4 32
First in 2000; this study’s year is marked. 17 started in 2015.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 1,400 is above the median of 111 across 551 interventional studies indexed under Delirium.
Median enrollment 84 across the 194 interventional studies, 124 across the 69 observational. Of the 171 that completed or were terminated, 68 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 263 have an industry lead sponsor. The 10 most frequent:
Washington University School of Medicine is the lead sponsor of 1,806 studies on the registry; 271 are open to participants now.
Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.
Washington University School of Medicine has 6 studies filed under Delirium — fewer than ten, so there is no comparison to draw.
22 of the studies in Delirium with a site in United States that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05431595Phase 3M.D. Anderson Cancer CenterManaging Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy | 2027-02-02 |
| NCT06969287Phase 3Washington University School of MedicineMitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery | 2027-04-01 |
| NCT06192615Phase 3Massachusetts General HospitalMinimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II) | 2027-10-31 |
| NCT03182335University of ChicagoVasopressor SAT Study | 2026-11 |
| NCT05127265University of FloridaPervasive Sensing and AI in Intelligent ICU | 2026-12 |
Add all 22 to your calendar (.ics) → With an account.
Among the 263 studies in Delirium with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to determine whether, compared with usual anesthetic care, an electroencephalography-guided anesthesia protocol is effective at preventing postoperative delirium and its downstream effects, and improving postoperative patient reported health-related quality of life.
Delirium is one of several geriatric syndromes, and is among the most common postoperative complications, affecting up to 70% of surgical patients older than 60. Delirium is an acute change that manifests as inattention and inability to think logically, and is deeply distressing to patients and their families. Based on our surveys of 1,000 surgical patients, over 30% were worried about experiencing delirium. Delirious patients are unable to participate effectively in rehabilitation exercises and are susceptible to other geriatric syndromes, like falls. The occurrence and duration of delirium are associated with longer intensive care unit and hospital stay, persistent cognitive deterioration, hospital readmission and increased mortality rate. Additionally, delirium carries a huge social and economic burden, costing over $60,000 per patient per year. Despite the importance of delirium to patients and to society, no approach has been proven to prevent postoperative delirium. Furthermore postoperative delirium is frequently unrecognized, and surgical patients are not followed systematically after they are discharged from hospital. Without diagnosing delirium or following patients postoperatively, we are limited in our ability to test the effectiveness of any intervention to prevent or treat postoperative delirium and its sequelae. There is mounting evidence that electroencephalography guidance of general anesthesia can decrease postoperative delirium. Specifically, our group has found that a suppressed electroencephalogram pattern, which occurs with deep anesthesia, is associated with increased delirium and death after surgery. The Electroencephalography Guidance of Anesthesia to Alleviate Geriatric Syndromes (ENGAGES) Study will therefore compare the effectiveness of two anesthetic protocols for reduction of postoperative delirium. One protocol will be based on current standard anesthetic practice, and the other protocol will be based on electroencephalography guidance. We also expect to determine the impact of the anesthetic protocols on patient reported outcomes of health-related quality of life. At Washington University, we have successfully implemented an ambitious study that enrolls patients at the preoperative assessment clinic, and tracks their health and wellbeing at 30 days and at 1-year postoperatively. This will enable us to assess the consequences of postoperative delirium and to determine whether anesthetic management can impact patient reported outcomes, such as health-related quality of life. We shall also explore whether a multi-component safety intervention for delirious patients prevents downstream adverse events, like falls. The ENGAGES study - through its structured anesthesia protocols, its thorough approach to delirium assessment, and its ability to track patients' health and wellbeing postoperatively - is poised to make a major contribution to the care of elderly patients who are at risk of postoperative delirium and other adverse outcomes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusions
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will have a pragmatic EEG-guided anesthetic protocol during their surgery. Practitioners will modify administration of anesthesia in an attempt to limit the occurrence of EEG burst suppression or persistent suppression.
Device: a pragmatic EEG-guided anesthetic protocol
Participants will have the standard anesthetic protocol.
Also known as: Bispectral Index proprietary processed EEG monitor
Number of Participants With Delirium
Delirium will be assessed at baseline and then once a day postoperative for up to 5 days. Patients were assessed for delirium using the Confusion Assessment Method for verbal patients or the Confusion Assessment Method for the Intensive Care Unit for non verbal or intubated patients, and patients medical records were reviewed for evidence of delirium by doctors and nurses assessments. Patients were considered to have delirium by any modality at anytime postoperative day one through five.
Time frame: 5 days
The Number of Participants With Postoperative Falls
The hypothesis is that the EEG-guided anesthetic protocol and providing a safety intervention will prevent subsequent injurious falls. Falls will be assessed using the Prevention of Falls Network Europe (ProFaNE) questions. At baseline questions will be asked about preoperative falls, and at 30-days and 1-year postoperatively, questions will be asked about postoperative falls.
Time frame: Up to 1 year postoperatively
Health Related Quality of Life
The hypothesis is that the EEG-guided anesthetic protocol will improve postoperative quality of life. Patient self-reported Health-related Quality of Life information will be assessed through the Veteran's RAND 12-item Health Survey at baseline and during follow-up (30-day and 1-year). The 12-item survey results in two summary scores called the Physical Composite Summary and the Mental Composite Summary. Each of these summary scores takes values between 0 and 100, where higher values represent better quality of life.
Time frame: Up to one year postoperatively
Duration of Delirium
Duration will be calculated by the number of positive CAM,CAM-ICU or delirium chart reviews.
Time frame: 5 days
Agreements Between the Family Confusion Assessment Method (FAM-CAM), and Researchers' Delirium Assessments and Confusion Assessment Method (CAM), Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) or Delirium Chart Reviews
Families of some patients in the ENGAGES trial and "The Prevention of Delirium and Complications Associated with Surgical Treatments" study (NCT01690988) completed FAM-CAM assessments in the afternoon. The FAM-CAM results in a binary classification of presence/absence of delirium. All time points between postoperative day 1-3 with concurrent family-completed FAM-CAM assessments and researcher-completed CAM/CAM-ICU assessments were included. Both arms of both trials were included together to minimize the risk of sampling bias due to a low rate of the FAM-CAM surveys returned. Delirium incidence using each assessment tool was quantified. Agreement between the concurrent FAM-CAM assessments and CAM/CAM-ICU assessments was quantified using repeated measures Cohen's kappa.
Time frame: 3 days
Incidence of Post-discharge Delirium
Defined as a positive FAM-CAM assessment between hospital discharge and postoperative day 30
Time frame: Postoperative day 30
Maximum Postoperative Pain (Patient Reported and Observational)
Pain was measured daily from postoperative day 1-5 using both patient-report and observational modalities. Patient-reported pain at rest was assessed using the visual analog scale (VAS), with possible scores ranging from 0 to 100 and higher scores indicating worse pain. The maximum VAS score between postoperative days 1-5 is reported here. Observational pain was assessed using the Behavioral Pain Scale (BPS) for intubated patients or the Behavioral Pain Scale - Non-Intubated (BPS-NI) for non-intubated patients. BPS and BPS-NI scores range from 3 to 12, with higher scores indicating worse pain. The maximum BPS or BPS-NI score between postoperative days 1-5 is reported here.
Time frame: 5 days
Postoperative Actigraphy
Postoperative disturbances in sleep abnormalities have previously been associated with postoperative delirium. Measures of root mean-squared activity (RMSactivity) was calculated by combining counts (binned in 1-minute intervals) across all three accelerometer axes (X, Y, and Z) from 16:00 on the day of surgery to 6:00 the following day. Median activity count was calculated from all minutes with nonzero RMS activity within each epoch- higher values indicate more movement.
Time frame: 1 day
Relationship Between Clinical CAM-ICU and Rigorous Delirium Assessments
Routine clinical (i.e. conducted by ICU nursing staff) delirium assessments in the intensive care units (conducted with the CAM-ICU) will be collected when these are available. Comparison will be made on the outcome of the assessment (positive for delirium or negative by delirium) between these routine clinical assessments and the assessments made by the research team. Since the purpose of this is to determine whether clinical staff are picking up episodes of delirium compared to researcher's assessment in all patients regardless of treatment group, data from both treatment arms were combined for the analysis.
Time frame: 5 days
One-year All-cause Mortality
Death from any cause within one year
Time frame: 1 year
One-year All-cause Mortality (Stratified by Treatment Arm and Delirium Status)
Death from any cause within one year (stratified by treatment arm and delirium status)
Time frame: 1 year
Delirium Prediction Models
It is important to improve our understanding of factors that are associated with an increased incidence of postoperative delirium or perhaps may even mediate an elevated risk for postoperative delirium. The arm/group was included in the model to determine if it was associated with postoperative delirium therefore data is not presented by arm/group.
Time frame: 5 days
Number of Participants With Severe Delirium
The severity of delirium will be scored using the CAM-Severity (CAM-S) metric, which has specifically been shown to be strongly associated with clinically relevant outcomes. Severe delirium was defined as patients with a CAM-S score of 10 or greater (range 0-19).
Time frame: 5 days
EEG and Delirium
A subset of patients underwent postoperative EEG with a limited montage (F8, O2, Cz electrodes) in the resting eyes open and eyes closed states concurrently with the delirium assessments on postoperative days 1-5. Frontal and occipital relative spectral power in three frequency bands (delta = 1-4 Hz, theta = 4-8 Hz, alpha = 8-13 Hz) was calculated at each time point. The discriminative ability of each relative spectral power component to detect delirium was quantified using area under the receiver operating characteristic curve (labeled as "probability" below).
Time frame: 5 days
Postoperative Actigraphy- Immobile Minutes
Postoperative disturbances in sleep abnormalities have previously been associated with postoperative delirium. Measures of root mean-squared activity (RMSactivity) was calculated by combining counts (binned in 1-minute intervals) across all three accelerometer axes (X, Y, and Z) from 16:00 on the day of surgery to 6:00 the following day. We quantified inactivity using the number of immobile minutes, defined as the total number of minutes with an RMSactivity count of zero- higher number indicates patient had more time being immobile.
Time frame: 1 day
Falls at One Year
Falls were detected via patient report on a survey administered 1 year following surgery. The question defined a fall as "an event in which you lost your balance and landed on the floor or ground or lower level."
Time frame: 1 year
ICU Length of Stay
Number of calendar days the patient was admitted to the ICU following surgery
Time frame: 1 year
Hospital Length of Stay
Number of calendar days the patient was admitted to the hospital following surgery
Time frame: 1 year
| Milestone | EEG Guided Protocol | Control Arm |
|---|---|---|
| Started | 614 | 618 |
| Completed | 614 | 618 |
| Not completed | 0 | 0 |
Delirium will be assessed at baseline and then once a day postoperative for up to 5 days. Patients were assessed for delirium using the Confusion Assessment Method for verbal patients or the Confusion Assessment Method for the Intensive Care Unit for non verbal or intubated patients, and patients medical records were reviewed for evidence of delirium by doctors and nurses assessments. Patients were considered to have delirium by any modality at anytime postoperative day one through five.
| Participants | EEG Guided Protocol | Control Arm |
|---|---|---|
| Number of Participants With Delirium | 157 | 140 |
The hypothesis is that the EEG-guided anesthetic protocol and providing a safety intervention will prevent subsequent injurious falls. Falls will be assessed using the Prevention of Falls Network Europe (ProFaNE) questions. At baseline questions will be asked about preoperative falls, and at 30-days and 1-year postoperatively, questions will be asked about postoperative falls.
| Participants | EEG Guided Protocol | Control Arm |
|---|---|---|
| The Number of Participants With Postoperative Falls | 136 | 135 |
The hypothesis is that the EEG-guided anesthetic protocol will improve postoperative quality of life. Patient self-reported Health-related Quality of Life information will be assessed through the Veteran's RAND 12-item Health Survey at baseline and during follow-up (30-day and 1-year). The 12-item survey results in two summary scores called the Physical Composite Summary and the Mental Composite Summary. Each of these summary scores takes values between 0 and 100, where higher values represent better quality of life.
| score on a scale | EEG Guided Protocol | Control Arm |
|---|---|---|
| Physical Composite Summary | 43.5 (32.1 to 52.1) | 42.8 (30.6 to 51.7) |
| Mental Composite Summary | 58.0 (17.5 to 62.0) | 58.3 (50.7 to 61.9) |
Duration will be calculated by the number of positive CAM,CAM-ICU or delirium chart reviews.
| days | EEG Guided Protocol | Control Arm |
|---|---|---|
| Duration of Delirium | 1 (1 to 3) | 1 (1 to 3) |
Families of some patients in the ENGAGES trial and "The Prevention of Delirium and Complications Associated with Surgical Treatments" study (NCT01690988) completed FAM-CAM assessments in the afternoon. The FAM-CAM results in a binary classification of presence/absence of delirium. All time points between postoperative day 1-3 with concurrent family-completed FAM-CAM assessments and researcher-completed CAM/CAM-ICU assessments were included. Both arms of both trials were included together to minimize the risk of sampling bias due to a low rate of the FAM-CAM surveys returned. Delirium incidence using each assessment tool was quantified. Agreement between the concurrent FAM-CAM assessments and CAM/CAM-ICU assessments was quantified using repeated measures Cohen's kappa.
| Participants | EEG Guided Protocol/ Control Group |
|---|---|
| Number of Patients with Positive FAM-CAM Assessments | 183 |
| Number of Patients with Positive CAM/CAM-ICU Assessments | 154 |
Defined as a positive FAM-CAM assessment between hospital discharge and postoperative day 30
| Participants | EEG Guided Protocol | Control Arm |
|---|---|---|
| Incidence of Post-discharge Delirium | 8 | 10 |
Pain was measured daily from postoperative day 1-5 using both patient-report and observational modalities. Patient-reported pain at rest was assessed using the visual analog scale (VAS), with possible scores ranging from 0 to 100 and higher scores indicating worse pain. The maximum VAS score between postoperative days 1-5 is reported here. Observational pain was assessed using the Behavioral Pain Scale (BPS) for intubated patients or the Behavioral Pain Scale - Non-Intubated (BPS-NI) for non-intubated patients. BPS and BPS-NI scores range from 3 to 12, with higher scores indicating worse pain. The maximum BPS or BPS-NI score between postoperative days 1-5 is reported here.
| units on a scale | EEG Guided Protocol | Control Arm |
|---|---|---|
| Maximum VAS Score | 32 (11.5 to 58) | 29.5 (13 to 52) |
| Maximum BPS/BPS-NI Score | 3 (3 to 4) | 3 (3 to 4) |
Postoperative disturbances in sleep abnormalities have previously been associated with postoperative delirium. Measures of root mean-squared activity (RMSactivity) was calculated by combining counts (binned in 1-minute intervals) across all three accelerometer axes (X, Y, and Z) from 16:00 on the day of surgery to 6:00 the following day. Median activity count was calculated from all minutes with nonzero RMS activity within each epoch- higher values indicate more movement.
| minutes RMSactivity>0 | No Delirium | Delirium POD 0-1 | Delirium POD 2-5 |
|---|---|---|---|
| Postoperative Actigraphy | 134 (59 to 195) | 101 (50 to 141) | 93 (36 to 236) |
Routine clinical (i.e. conducted by ICU nursing staff) delirium assessments in the intensive care units (conducted with the CAM-ICU) will be collected when these are available. Comparison will be made on the outcome of the assessment (positive for delirium or negative by delirium) between these routine clinical assessments and the assessments made by the research team. Since the purpose of this is to determine whether clinical staff are picking up episodes of delirium compared to researcher's assessment in all patients regardless of treatment group, data from both treatment arms were combined for the analysis.
| Cohen's kappa coefficient | Patients With Nursing ICU Assessment |
|---|---|
| Relationship Between Clinical CAM-ICU and Rigorous Delirium Assessments | 0.37 (0.29 to 0.44) |
Death from any cause within one year
| Participants | EEG Guided Protocol | Control Arm |
|---|---|---|
| One-year All-cause Mortality | 57 | 62 |
Death from any cause within one year (stratified by treatment arm and delirium status)
| Participants | EEG-guided Protocol - With Postoperative Delirium | EEG Guided Protocol - Without Postoperative Delirium | Control Arm - With Postoperative Delirium | Control Arm - Without Postoperative Delirium |
|---|---|---|---|---|
| One-year All-cause Mortality (Stratified by Treatment Arm and Delirium Status) | 28 | 29 | 19 | 43 |
It is important to improve our understanding of factors that are associated with an increased incidence of postoperative delirium or perhaps may even mediate an elevated risk for postoperative delirium. The arm/group was included in the model to determine if it was associated with postoperative delirium therefore data is not presented by arm/group.
| odds ratio | Regression Analysis |
|---|---|
| Guided Group | 1.12 (0.30 to 1.64) |
| Age | 1.04 (1.02 to 1.06) |
| Male | 0.99 (0.71 to 1.38) |
| White | 0.46 (0.28 to 0.74) |
| Living alone | 0.91 (0.63 to 1.32) |
| Hearing aid use | 0.82 (0.52 to 1.30) |
| No. Comorbidities | 1.08 (1.01 to 1.16) |
| ASA greater than 3 | 1.98 (1.27 to 3.09) |
| Marginal exercise tolerance less than 4 METS | 1.21 (0.86 to 1.70) |
| Falls in previous 6 months | 1.25 (0.88 to 1.76) |
| History of delirium | 1.83 (1.21 to 2.76) |
| Preoperative PHQ8 | 1.03 (0.99 to 1.07) |
| Preoperative Lawton | 0.95 (0.83 to 1.09) |
| Preoperative Barthel | 0.95 (0.81 to 1.12) |
| Preoperative opioids | 1.27 (0.88 to 1.82) |
| Preoperative benzodiazepines | 1.28 (0.85 to 1.94) |
| Preoperative sodium level | 0.98 (0.94 to 1.03) |
| Preoperative creatinine level | 1.06 (0.91 to 1.22) |
| Preoperative hemoglobin level | 0.99 (0.91 to 1.08) |
| Cardiac surgery | 0.92 (0.58 to 1.44) |
The severity of delirium will be scored using the CAM-Severity (CAM-S) metric, which has specifically been shown to be strongly associated with clinically relevant outcomes. Severe delirium was defined as patients with a CAM-S score of 10 or greater (range 0-19).
| Participants | EEG Guided Protocol | Control Arm |
|---|---|---|
| Number of Participants With Severe Delirium | 59 | 51 |
A subset of patients underwent postoperative EEG with a limited montage (F8, O2, Cz electrodes) in the resting eyes open and eyes closed states concurrently with the delirium assessments on postoperative days 1-5. Frontal and occipital relative spectral power in three frequency bands (delta = 1-4 Hz, theta = 4-8 Hz, alpha = 8-13 Hz) was calculated at each time point. The discriminative ability of each relative spectral power component to detect delirium was quantified using area under the receiver operating characteristic curve (labeled as "probability" below).
| Probability | Enrolled Patients |
|---|---|
| Occipital alpha, eyes closed | 0.75 (0.58 to 0.87) |
| Occipital alpha, eyes open | 0.73 (0.54 to 0.85) |
| Occipital theta, eyes closed | 0.64 (0.43 to 0.84) |
| Occipital theta, eyes open | 0.60 (0.37 to 0.78) |
| Occipital delta, eyes closed | 0.68 (0.50 to 0.82) |
| Frontal alpha, eyes closed | 0.75 (0.57 to 0.88) |
| Frontal alpha, eyes open | 0.62 (0.41 to 0.81) |
| Frontal theta, eyes closed | 0.45 (0.27 to 0.69) |
| Frontal theta, eyes open | 0.59 (0.37 to 0.77) |
| Frontal delta, eyes closed | 0.67 (0.43 to 0.84) |
| Frontal delta, eyes open | 0.55 (0.30 to 0.74) |
Postoperative disturbances in sleep abnormalities have previously been associated with postoperative delirium. Measures of root mean-squared activity (RMSactivity) was calculated by combining counts (binned in 1-minute intervals) across all three accelerometer axes (X, Y, and Z) from 16:00 on the day of surgery to 6:00 the following day. We quantified inactivity using the number of immobile minutes, defined as the total number of minutes with an RMSactivity count of zero- higher number indicates patient had more time being immobile.
| minutes RMSactivity=0 | No Delirium | Delirium POD 0-1 | Delirium POD 2-5 |
|---|---|---|---|
| Postoperative Actigraphy- Immobile Minutes | 548 (472 to 625) | 584 (430 to 620) | 604 (440 to 683) |
Falls were detected via patient report on a survey administered 1 year following surgery. The question defined a fall as "an event in which you lost your balance and landed on the floor or ground or lower level."
| Participants | EEG Guided Protocol | Control Arm |
|---|---|---|
| Falls at One Year | 136 | 135 |
Number of calendar days the patient was admitted to the ICU following surgery
| Days | EEG Guided Protocol | Control Arm |
|---|---|---|
| ICU Length of Stay | 3 (2 to 5) | 3 (2 to 5) |
Number of calendar days the patient was admitted to the hospital following surgery
| Days | EEG Guided Protocol | Control Arm |
|---|---|---|
| Hospital Length of Stay | 7 (5 to 11) | 7 (5 to 11) |
Collected over Adverse events were collected during surgery up to 30 days postoperatively. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| EEG Guided Protocol | 4/614 (0.7%) | 124/614 (20.2%) | 361/614 (58.8%) |
| Control Arm | 20/618 (3.2%) | 130/618 (21%) | 345/618 (55.8%) |
| Event | EEG Guided Protocol | Control Arm |
|---|---|---|
| Respiratory FailuresRespiratory, thoracic and mediastinal disorders | 21/614 | 27/618 |
| Other GI eventGastrointestinal disorders | 14/614 | 18/618 |
| Other body system eventSurgical and medical procedures | 12/614 | 14/618 |
| Wound infectionImmune system disorders | 11/614 | 13/618 |
| Ileus/bowel obstructionGastrointestinal disorders | 12/614 | 8/618 |
| Cardiac ArrestCardiac disorders | 1/614 | 12/618 |
| Bleeding/anemia requiring unexpected transfusionBlood and lymphatic system disorders | 5/614 | 11/618 |
| SepsisImmune system disorders | 9/614 | 11/618 |
| StrokeNervous system disorders | 10/614 | 4/618 |
| PneumoniaRespiratory, thoracic and mediastinal disorders | 10/614 | 3/618 |
| Event | EEG Guided Protocol | Control Arm |
|---|---|---|
| Bleeding/anemia requiring unexpected transfusionBlood and lymphatic system disorders | 121/614 | 126/618 |
| Unexpected atrial fibrillationCardiac disorders | 73/614 | 97/618 |
| Acute kidney injuryRenal and urinary disorders | 40/614 | 40/618 |
| Urinary retentionRenal and urinary disorders | 36/614 | 28/618 |
| ThrombocytopeniaBlood and lymphatic system disorders | 24/614 | 23/618 |
| Other respiratory eventRespiratory, thoracic and mediastinal disorders | 24/614 | 17/618 |
| Ileus/bowel obstructionGastrointestinal disorders | 22/614 | 22/618 |
| UTIImmune system disorders | 20/614 | 19/618 |
| Other renal eventRenal and urinary disorders | 20/614 | 20/618 |
| Other immune eventImmune system disorders | 19/614 | 14/618 |
| Age, Continuous(years) | EEG Guided Protocol | Control Arm | Total |
|---|---|---|---|
| Median | 69.5 (65.0 to 74.7) | 69.4 (64.7 to 75.8) | 69.5 (64.8 to 75.0) |
| Sex: Female, Male(Participants) | EEG Guided Protocol | Control Arm | Total |
|---|---|---|---|
| Female | 282 | 281 | 563 |
| Male | 332 | 337 | 669 |
| Race/Ethnicity, Customized(participants) | EEG Guided Protocol | Control Arm | Total |
|---|---|---|---|
| White | 555 | 558 | 1113 |
| Black | 54 | 53 | 107 |
| Other | 5 | 7 | 12 |
| Region of Enrollment(Participants) | EEG Guided Protocol | Control Arm | Total |
|---|---|---|---|
| United States | 614 | 618 | 1232 |
| BMI(kg/m^2) | EEG Guided Protocol | Control Arm | Total |
|---|---|---|---|
| Median | 29.0 (25.0 to 33.0) | 29.0 (25.0 to 33.0) | 29.0 (25.0 to 33.0) |
| Attended College(Participants) | EEG Guided Protocol | Control Arm | Total |
|---|---|---|---|
| Count of participants | 198 | 208 | 406 |
| Lifetime tobacco use(Participants) | EEG Guided Protocol | Control Arm | Total |
|---|---|---|---|
| Count of participants | 376 | 349 | 725 |
| Number of Participants with a Weekly Alcohol Intake(Participants) | EEG Guided Protocol | Control Arm | Total |
|---|---|---|---|
| Count of participants | 289 | 297 | 586 |
20 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Ran from Jan 2015 to primary completion in May 2018, 40 months.
Results were first posted in Jun 2019, 1 year 1 month after primary completion.
Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 40 months is above that.
Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Washington University School of Medicine →